Pharmacotherapy of Chronic Kidney Disease

Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS

About This Course

  • Recorded August 29, of 2024 and valid through August 29, 2027

  • Price $50 for 2 Hours

  • ON DEMAND 2024-08-29 Pharmacotherapy of Chronic Kidney Disease

Learning Objectives

  1. Discuss the mechanisms of action, role and pros/cons of SGLT2-inhibitors, GLP-1 inhibitors and finerenone in the prevention of CKD progression.

  2. Describe the mechanisms of action, role and pros/cons of therapies for the management of hyperkalemia in patients with CKD.

  3. Choose appropriate therapy for the management of hyperkalemia in a patient with CKD.

  4. Describe the mechanisms of action, role, and pros/cons of therapies for the management of anemia in patients with CKD.

  5. Initiate appropriate iron and ESA therapy in a patient with anemia and CKD.

  6. Discuss the roles of phosphate, calcium, vitamin D and parathyroid hormone in the development of Chronic Kidney Disease – Mineral and Bone Disorder (CKD-MBD)

  7. Describe the mechanisms of action, and pros/cons of therapies for the management of CKD-MBD.

  8. Choose an appropriate therapy for the management of hyperphosphatemia, low vitamin D and secondary hyperparathyroidism in a patient with CKD. 

I am thankful that she told us about the latest guidelines that were updated 2 days ago.

This was a really good presentation. It made me realize I need to brush up on my CKD knowledge, especially in the setting of anemia and Bone-Mineral Density.

The presenter was knowledgeable and displayed her expertise in the practice setting
— Kudos for Dr. Vondracek 12/2024
Purchase Course
Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS

Dr. Sheryl (Follin) Vondracek, Pharm.D., FCCP, BCPS

Clinical Professor, University of Georgia College of Pharmacy, Savannah, GA.Clinical Pharmacy Specialist, St. Joseph’s Candler Health System, Savannah, GA.
Co-founder of Southeastern Research Group Endeavor (SERGE45) and TeachMePharm

Accreditation Information

PHARMACISTS :University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists. On-demand courses provide HOME STUDY credit only.

CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.

CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).  This credit is applicable to health professionals who may require pharmacology credit.

NURSE PRACTITIONERS: This course fulfills the pharmacotherapeutics/ pharmacology requirements for American Nurses Credentialing Center (ANCC) Category 1 Continuing Education Hours  for certification renewal as well as other Nurse Practitioner credentialing organizations. The same hours submitted to renew certification may be submitted to a State Board of Nursing for re-licensure. American Nurses Credentialing Center (ANCC) accepts formally approved continuing education sponsored by organizations accredited or approved by the Accreditation Council for Pharmacy Education (ACPE).

American Academy of Nurse Practitioners (AANP) accepts on demand courses approved for AMA PRA Category 1 Credit™. This program offers Category 2 credit only.

NURSES: University Learning Systems is Approved by the California Board of Registered Nursing, Provider Number CEP 11409, CE Broker: Arkansas, District of Columbia, Florida, Georgia, Kentucky, New Mexico, and West Virginia, Boards of Nursing.

PHYSICIANS: This CME program offers Category 2 credit.

  • CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive MAINPRO-M2 credits for participation in this activity.

PHYSICIAN ASSISTANTS: This CME program offers Category 2 credit.

OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval.